Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo

Julie Lagirand-Cantaloube, Karen Cornille, Alfredo Csibi et al. · 2009

Read Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo by Julie Lagirand-Cantaloube, Karen Cornille, Alfredo Csibi et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004973.txt.

Description

Muscle wasting follows bed rest, illness and starvation. A protein-shredding enzyme called Atrogin-1 drives much of that loss. Its substrates during wasting were poorly known. Julie Lagirand-Cantaloube and colleagues studied one target in PLOS ONE in 2009. The target is MyoD. MyoD controls muscle stem cell function and specialization.

Atrogin-1 tags MyoD for destruction by the proteasome. Blocking Atrogin-1 protected MyoD in living mice. With MyoD spared, skeletal muscle atrophy was prevented. The study flags the shredder as a drug target. Stopping it might protect patients whose muscles waste away during illness or immobility.

Catalog record

CREATORJulie Lagirand-Cantaloube, Karen Cornille, Alfredo Csibi et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004973

Browse the full library · About the Tower of Babel